Sleep disruption due to nocturnal heartburn: a review of the evidence and clinical implications

Q4 Biochemistry, Genetics and Molecular Biology Exploration of medicine Pub Date : 2023-12-25 DOI:10.37349/emed.2023.00191
David A. Johnson, Amisha M. Parikh-Das, Evren Atillasoy, Hayk Davtyan, Leslie Shur, Andrea S. Blevins-Primeau, Nathaniel F. Watson
{"title":"Sleep disruption due to nocturnal heartburn: a review of the evidence and clinical implications","authors":"David A. Johnson, Amisha M. Parikh-Das, Evren Atillasoy, Hayk Davtyan, Leslie Shur, Andrea S. Blevins-Primeau, Nathaniel F. Watson","doi":"10.37349/emed.2023.00191","DOIUrl":null,"url":null,"abstract":"Nocturnal heartburn (NHB) is a symptom that affects up to 25% of the general population and has been shown to cause sleep disruption that adversely affects quality of life and psychomotor performance. Few studies have evaluated the association between occasional NHB and sleep disturbances; therefore, this connection may be underappreciated and left untreated by the primary care provider and patient, with potentially significant negative clinical consequences and effects on quality of life. This review sought to describe what is currently known about the interplay between occasional NHB and sleep disruption, and identify whether acid suppression therapy can improve symptoms of occasional NHB and associated sleep disruptions. The pathophysiology of heartburn-induced sleep disruption appears to follow a bidirectional cycle due to the normal physiologic changes that occur in the upper gastrointestinal tract during sleep and due to the potential for heartburn symptoms to cause sleep arousal. The majority of the identified studies suggested that pharmacologic interventions for acid reduction, including proton pump inhibitors or histamine type-2 receptor antagonists (H2RAs), improved objective and/or subjective sleep outcomes among individuals with gastroesophageal reflux disease (GERD) and NHB. Several studies specific to famotidine demonstrated that treatment with 10 mg or 20 mg reduced nighttime awakenings due to NHB. In conclusion, NHB symptoms can cause sleep dysfunction that can have a profound adverse downstream effect on quality of life, next-day functioning, and health-related outcomes. The current approach to managing occasional NHB is similar to that associated with GERD, highlighting the need for studies specific to the occasional heartburn population. Health care providers should investigate NHB as one of the potential causes of sleep complaints, and patients with heartburn should be questioned about sleep quality, recalled arousals, next-day vitality, early fatigue, and next-day functioning.","PeriodicalId":72999,"journal":{"name":"Exploration of medicine","volume":"26 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploration of medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37349/emed.2023.00191","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Nocturnal heartburn (NHB) is a symptom that affects up to 25% of the general population and has been shown to cause sleep disruption that adversely affects quality of life and psychomotor performance. Few studies have evaluated the association between occasional NHB and sleep disturbances; therefore, this connection may be underappreciated and left untreated by the primary care provider and patient, with potentially significant negative clinical consequences and effects on quality of life. This review sought to describe what is currently known about the interplay between occasional NHB and sleep disruption, and identify whether acid suppression therapy can improve symptoms of occasional NHB and associated sleep disruptions. The pathophysiology of heartburn-induced sleep disruption appears to follow a bidirectional cycle due to the normal physiologic changes that occur in the upper gastrointestinal tract during sleep and due to the potential for heartburn symptoms to cause sleep arousal. The majority of the identified studies suggested that pharmacologic interventions for acid reduction, including proton pump inhibitors or histamine type-2 receptor antagonists (H2RAs), improved objective and/or subjective sleep outcomes among individuals with gastroesophageal reflux disease (GERD) and NHB. Several studies specific to famotidine demonstrated that treatment with 10 mg or 20 mg reduced nighttime awakenings due to NHB. In conclusion, NHB symptoms can cause sleep dysfunction that can have a profound adverse downstream effect on quality of life, next-day functioning, and health-related outcomes. The current approach to managing occasional NHB is similar to that associated with GERD, highlighting the need for studies specific to the occasional heartburn population. Health care providers should investigate NHB as one of the potential causes of sleep complaints, and patients with heartburn should be questioned about sleep quality, recalled arousals, next-day vitality, early fatigue, and next-day functioning.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
夜间胃灼热引起的睡眠障碍:证据综述与临床意义
夜间胃灼热(NHB)是一种影响高达 25% 的普通人群的症状,已被证实会导致睡眠紊乱,从而对生活质量和精神运动表现产生不利影响。很少有研究对偶发性 NHB 与睡眠障碍之间的关系进行评估;因此,初级保健提供者和患者可能没有充分认识到这种关系,也没有对其进行治疗,从而可能对临床后果和生活质量造成严重的负面影响。本综述旨在描述目前已知的偶发性 NHB 与睡眠障碍之间的相互作用,并确定抑酸疗法是否能改善偶发性 NHB 症状及相关的睡眠障碍。由于上消化道在睡眠期间会发生正常的生理变化,同时胃灼热症状也可能导致睡眠唤醒,因此胃灼热诱发睡眠障碍的病理生理学似乎遵循一个双向循环。大多数已确定的研究表明,药物降酸干预(包括质子泵抑制剂或组胺 2 型受体拮抗剂 (H2RA))可改善胃食管反流病 (GERD) 和 NHB 患者的客观和/或主观睡眠效果。几项专门针对法莫替丁的研究表明,10 毫克或 20 毫克的治疗可减少 NHB 引起的夜间觉醒。总之,NHB 症状可导致睡眠功能障碍,从而对生活质量、第二天的工作能力和健康相关结果产生深远的负面影响。目前管理偶发性 NHB 的方法与胃食管反流病的相关方法类似,因此需要针对偶发性胃灼热人群进行专门研究。医疗服务提供者应将 NHB 作为睡眠不适的潜在原因之一进行调查,并应询问胃灼热患者的睡眠质量、唤醒回忆、次日活力、早期疲劳和次日功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
0
审稿时长
13 weeks
期刊最新文献
The future of cervical cancer prevention: advances in research and technology Impact of vitamin D on ultraviolet-induced photoaging and skin diseases Physiologically driven nanodrug delivery system for targeted lung cancer treatment Effects of alimentary-derived bacterial metabolites on energy metabolism in colonic epithelial cells and inflammatory bowel diseases Medicinal and immunological aspects of bacteriophage therapy to combat antibiotic resistance
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1